| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |